Financial statements Pharm
Balance sheet data of PHARM
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 54 496,67 | 58 803,77 | 59 185,56 | 93 080,88 | 264 204,35 | 125 729,95 |
| A. Fixed assets | 50 000,00 | 50 000,00 | 50 000,00 | 50 000,00 | 50 000,00 | 50 000,00 |
| B. Current assets | 4 496,67 | 8 803,77 | 9 185,56 | 43 080,88 | 214 204,35 | 75 729,95 |
| C. Share capital contributions (basic funds) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| D. Own shares (stocks) | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| Total liabilities | 54 496,67 | 58 803,77 | 59 185,56 | 93 080,88 | 264 204,35 | 125 729,95 |
| A. Equity | 23 272,06 | 13 853,45 | 41 804,90 | 69 055,53 | 241 934,94 | 104 747,80 |
| B. Liabilities and provisions for liabilities | 31 224,61 | 44 950,32 | 17 380,66 | 24 025,35 | 22 269,41 | 20 982,15 |
| I. Long-term liabilities | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
| II. Short-term liabilities | 31 224,61 | 44 950,32 | 17 380,66 | 24 025,35 | 22 269,41 | 20 982,15 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.